Tech Company Financing Transactions
Naia Funding Round
Naia closed a $5.3 million Series A investment round on 10/20/2015. Investors included private investors.
Transaction Overview
Company Name
Announced On
10/20/2015
Transaction Type
Venture Equity
Amount
$5,300,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to continue to invest in its subsidiaries and their portfolio of therapeutic approaches, including a program focused on the treatment of SBS, an orphan indication.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA 94103
USA
San Francisco, CA 94103
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Naia Limited is a privately-held, international drug development company that employs an innovative global strategy to clinically advance drug candidates.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Perez
Chief Financial Officer
Mark Bagnall
Browse more venture capital transactions:
Prev: 10/20/2015: Collective Health venture capital transaction
Next: 10/20/2015: WaveCrest Group venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to document funding rounds that are announced publicly. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs